Skip to main content
Menu Icon Menu Icon

FCPA Scorecard Blog

Foreign Corrupt Practices Act & Anti-Corruption


Subscribe to our FinCrimes Update for news about the Foreign Corrupt Practices Act and related prosecutions and enforcement actions.

  • Teva Self-Discloses Potential FCPA Violations

    In a February 9, 2015 securities filing, generic drug manufacturer Teva Pharmaceuticals disclosed that in the course of its internal investigation into business practices in various locations around the world, it had discovered certain practices in Russia, Europe, and Latin America that "likely" constitute violations of the FCPA. Teva had previously disclosed in 2012 that it received subpoenas and document requests from the SEC and the DOJ relating to the Company's FCPA compliance in certain countries.  Teva had also disclosed at that time that it was conducting an internal investigation into its FCPA-related compliance practice around the world.  During the course of the investigation, Teva reported that its affiliates in certain countries under investigation had provided "inaccurate or altered information relating to marketing or promotional practices" to local authorities, and that it had brought such issues to the attention of U.S. authorities.  The SEC and DOJ's investigations appear to be ongoing.

    Latin America Russia Teva Pharmaceuticals Europe

    Share page with AddThis
  • BizJet Resolves FCPA Matter with DOJ Related to Conduct in Latin America

    On March 14, 2012, aircraft maintenance, repair and overhaul ("MRO") provider, BizJet International Sales and Support, Inc., resolved an FCPA matter with the US DOJ related to conduct in Latin America, including Mexico and Panama.  The deferred-prosecution agreement calls for an $11.8 million penalty.  BizJet is an indirect subsidiary of the German company, Lufthansa Technik AG, which also entered a DPA.


    Mexico BizJet Panama Lufthansa Technik AG Latin America

    Share page with AddThis